Galectin Therapeutics Inc. (FRA:PHPN)
2.480
-0.080 (-3.13%)
At close: Jan 16, 2026
Galectin Therapeutics Market Cap
Galectin Therapeutics has a market cap or net worth of €153.57 million as of January 30, 2026. Its market cap has increased by 96.69% in one year.
Market Cap
153.57M
Enterprise Value
251.84M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.48
Market Cap Chart
Since September 4, 2002, Galectin Therapeutics's market cap has increased from 31.76M to 153.57M, an increase of 383.62%. That is a compound annual growth rate of 6.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 153.57M | -32.77% |
| Dec 31, 2025 | 228.43M | 192.11% |
| Dec 31, 2024 | 78.20M | -15.81% |
| Dec 29, 2023 | 92.88M | 47.83% |
| Dec 30, 2022 | 62.83M | -41.83% |
| Dec 31, 2021 | 108.01M | 3.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allane SE | 204.05M |
| Eleving Group | 186.27M |
| ADM Hamburg Aktiengesellschaft | 173.72M |
| Deutsche Real Estate AG | 172.89M |
| 029 Group SE | 156.00M |
| Greenland Resources | 151.41M |
| LEWAG Holding Aktiengesellschaft | 134.01M |
| Mineralbrunnen Überkingen-Teinach GmbH & Co. KGaA | 129.61M |